ABC Global Alliance and OncoDaily Announce Strategic Partnership to Advance Global Collaboration in Advanced Breast Cancer

ABC Global Alliance

Deadly Industry: Challenging Big Tobacco - The Second Series of the Podcast Exposing Corporate Tactics

Big Tobacco

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Betty Kim: Honored to Welcome a Forest of Nobel Prize Winners at MD Anderson Cancer Center

Betty Kim

Teresa Macarulla: Evolving Treatment Strategies for Resectable Gastric Cancer

Teresa Macarulla

Cristian Massacesi: Visiting the Bristol Myers Squibb Office in Shanghai for the First Time

Cristian Massacesi

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

Eduardo Bruera: Managing Opioid Use in Cancer Pain Through CHAT

Eduardo Bruera

OncoCalendar

« All Events

  • This event has passed.

LATAM Course II: Immunotherapy in Lung Cancer by IASLC

Dec 19, 2024 • 4:00 PM - 5:00 PM
LATAM Course II: Immunotherapy in Lung Cancer by IASLC

LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19th, 2024.

The exclusive course on the latest updates in lung cancer treatment in LATAM, with a special focus on immunotherapy, will take place in Series II. Renowned thoracic oncology experts from the region will explore the role of immunotherapy in revolutionizing lung cancer care. The discussions will cover crucial topics, including the integration of biomarkers for immunotherapy, optimal management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy will transform the landscape of lung cancer treatment in LATAM, offering hope for improved patient outcomes.

See the Speakers and Series II LATAM Team Below:

LATAM Course II: Immunotherapy in Lung Cancer by IASLC

Details

Date:
Dec 19, 2024
Time:
4:00 PM - 5:00 PM
Website:
https://www.iaslc.org/node/35047

Organizer

The International Association for the Study of Lung Cancer (IASLC)
Phone
1-855-464-2752
Email
info@iaslc.org